Tesamorelin Selectively Reduces Both Visceral Fat and Liver Fat in HIV-Positive Patients | RemedyX Labs Research Library

A research summary of Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial, examining tesamorelin selectively reduces both visceral fat and liver fat in hiv-positive patients. Cited source and RUO context from RemedyX Labs.